Revvity, Inc. (NYSE:RVTY) Holdings Lifted by Tidal Investments LLC

Tidal Investments LLC boosted its stake in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 82.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 96,459 shares of the company's stock after purchasing an additional 43,672 shares during the quarter. Tidal Investments LLC owned approximately 0.08% of Revvity worth $10,766,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in RVTY. Nissay Asset Management Corp Japan ADV raised its stake in Revvity by 0.6% during the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 15,023 shares of the company's stock valued at $1,682,000 after acquiring an additional 91 shares in the last quarter. Quarry LP raised its stake in Revvity by 45.7% during the 4th quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after acquiring an additional 95 shares in the last quarter. HB Wealth Management LLC raised its stake in Revvity by 4.6% during the 4th quarter. HB Wealth Management LLC now owns 2,380 shares of the company's stock valued at $266,000 after acquiring an additional 104 shares in the last quarter. Signaturefd LLC raised its stake in Revvity by 6.8% during the 4th quarter. Signaturefd LLC now owns 1,668 shares of the company's stock valued at $186,000 after acquiring an additional 106 shares in the last quarter. Finally, Westside Investment Management Inc. raised its stake in Revvity by 0.8% during the 4th quarter. Westside Investment Management Inc. now owns 14,363 shares of the company's stock valued at $1,603,000 after acquiring an additional 108 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Revvity Trading Down 1.1%

Shares of Revvity stock traded down $1.01 on Friday, reaching $89.47. 1,023,503 shares of the company were exchanged, compared to its average volume of 951,592. The stock has a fifty day moving average price of $96.71 and a 200-day moving average price of $109.21. The firm has a market capitalization of $10.55 billion, a price-to-earnings ratio of 40.48, a price-to-earnings-growth ratio of 3.82 and a beta of 1.02. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. Revvity, Inc. has a fifty-two week low of $88.01 and a fifty-two week high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. The company had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. Revvity had a return on equity of 7.68% and a net margin of 9.81%. Revvity's revenue for the quarter was up 2.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.98 earnings per share. On average, analysts expect that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date is Friday, July 18th. Revvity's dividend payout ratio (DPR) is presently 11.91%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on RVTY shares. Wall Street Zen downgraded Revvity from a "buy" rating to a "hold" rating in a research note on Saturday. JPMorgan Chase & Co. dropped their price objective on Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 29th. KeyCorp boosted their price objective on Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Wells Fargo & Company dropped their price objective on Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 17th. Finally, Raymond James reissued an "outperform" rating and issued a $120.00 price objective (down previously from $145.00) on shares of Revvity in a research note on Tuesday, April 29th. Five research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $125.64.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.